Sun Pharma became India’s largest drugmaker by mastering generics. Now a portfolio of skin, eye and cancer medicines - and an audacious pending Organon deal - is changing what the company wants to be.

From a high-school tungsten study to the quality desk of a global drugmaker, Christopher Leonor’s career is a study in the quiet systems that make pharmaceutical supply chains work.